Avapro and Haemoglobin increased - a phase IV clinical study of FDA data

Summary:

Haemoglobin increased is reported as a side effect among people who take Avapro (irbesartan), especially for people who are female, 60+ old, also take Morphine Sulfate, and have Pain.

The phase IV clinical study analyzes which people have Haemoglobin increased when taking Avapro. It is created by eHealthMe based on reports of 18,804 people who have side effects when taking Avapro from the FDA, and is updated regularly.

What is Avapro?

Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.

What is Haemoglobin increased?

Haemoglobin increased is found to be associated with 485 drugs and 533 conditions by eHealthMe. Check the latest studies of Haemoglobin increased.

On Apr, 22, 2026

18,804 people reported to have side effects when taking Avapro.
Among them, 16 people (0.09%) have Haemoglobin increased.

Could Avapro cause Haemoglobin increased?

Among these 16 people:

What is the gender of people who have Haemoglobin increased when taking Avapro? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Haemoglobin increased when taking Avapro? *

What are other drugs people take besides Avapro? *

What are other side effects people have besides Haemoglobin increased? *

Haematocrit Increased: 6 people, 37.50%
Insomnia (sleeplessness): 4 people, 25.00%
Serum Ferritin Increased: 3 people, 18.75%
Dyspnea (difficult or laboured breathing): 3 people, 18.75%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 18.75%
Oedema (fluid collection in tissue): 3 people, 18.75%
Orthopnea (shortness of breath (dyspnea) when lying down): 3 people, 18.75%
Pain: 3 people, 18.75%
Fatigue (feeling of tiredness): 3 people, 18.75%
Red Blood Cell Count Increased: 3 people, 18.75%

What are the existing conditions these people have? *

Pain: 4 people, 25.00%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 18.75%
Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 2 people, 12.50%
Neck Pain: 2 people, 12.50%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 2 people, 12.50%
Embolism Arterial (blood clot that has travelled through your arteries and become stuck): 2 people, 12.50%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 12.50%
Shunt Occlusion (blockage of shunt): 1 person, 6.25%
Osteoporosis (bones weak and more likely to break): 1 person, 6.25%
Nausea (feeling of having an urge to vomit): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Avapro and have Haemoglobin increased?

- Check whether Haemoglobin increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Avapro:

Avapro (19,840 reports)

Browse all side effects of Avapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemoglobin increased:

Haemoglobin increased (485 drugs)

Browse all the conditions that are associated with Haemoglobin increased:

Haemoglobin increased (533 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on irbesartan (the active ingredients of Avapro) and Avapro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.